Norman Fields Q2 2026 Investment Activity: Major Buys and Minor Adjustments

Norman Fields' portfolio saw significant changes in Q2 2026 with notable purchases of SLB Limited (SLB) and ARS Pharmaceuticals Inc. (SPRY), alongside minor adjustments to existing holdings.